Oxygenta Pharmaceutical Ltd
BSE: 524636
Revenue & Profit Trend
in croresMargin Trend
percentage| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 37.00-25.4% | 49.61+46.2% | 33.93+137.2% | 14.30-5.5% | 15.13-69.4% | 49.47+49.0% | 33.21+137.1% | 14.01 |
| Other Income | 0.02-86.5% | 0.17 | 0.00+100.0% | -0.06-133.2% | 0.17+244.4% | 0.05-89.9% | 0.49-34.8% | 0.75 |
| Total Income | 37.02-25.6% | 49.79+46.7% | 33.93+138.2% | 14.25-6.9% | 15.30-69.1% | 49.52+47.0% | 33.69+128.4% | 14.76 |
| EXPENSES | ||||||||
| Expenditure | 39.53-22.6% | 51.07+26.9% | 40.26+94.6% | 20.68-11.8% | 23.44-55.8% | 53.04+37.2% | 38.66+120.5% | 17.53 |
| Tax | -0.40-195.1% | 0.42+128.6% | -1.48+1.6% | -1.51+26.2% | -2.04-24.0% | -1.65-259.2% | 1.03+1176.5% | 0.08 |
| PROFIT | ||||||||
| PBT | -2.51-95.9% | -1.28+79.8% | -6.33+1.7% | -6.44+21.0% | -8.15-114.5% | -3.80+23.4% | -4.96-78.9% | -2.77 |
| Net Profit | -2.10-23.4% | -1.70+64.8% | -4.84+1.8% | -4.93+19.3% | -6.11-183.6% | -2.15+45.2% | -3.93-37.6% | -2.85 |
| KEY METRICS | ||||||||
| OPM % | 1.48%+1.25pp | 0.23%+12.24pp | -12.01%+19.98pp | -31.99%+13.21pp | -45.20%-41.25pp | -3.95%+15.76pp | -19.71%+15.08pp | -34.79% |
| NPM % | -5.68%-2.26pp | -3.42%+10.85pp | -14.27%+20.34pp | -34.61%+5.29pp | -39.90%-35.55pp | -4.35%+7.31pp | -11.66%+7.68pp | -19.34% |
| EPS | 0.57+26.7% | 0.45-65.9% | 1.32-0.8% | 1.33-19.4% | 1.65+175.0% | 0.60+156.1% | -1.07-32.1% | -0.81 |
Corporate Events
Board Meeting
The Board Meeting is scheduled to consider and approve the u…
BSE Filing ↗Board Meeting
Notice of the 33rd Annual General Meeting for the Financial …
BSE Filing ↗Board Meeting
The Board Meeting is scheduled to consider and approve the U…
BSE Filing ↗Board Meeting
The board meeting is scheduled to consider and approve the a…
BSE Filing ↗Board Meeting
Consider and approve audited financial results of the Fourth…
BSE Filing ↗Board Meeting
Consider and approve This is to inform you .... 2015 and all…
BSE Filing ↗Board Meeting
Consider and approve This is to inform you .... Oxygenta Pha…
BSE Filing ↗Board Meeting
Consideration and approval of raising of funds by way of iss…
BSE Filing ↗Board Meeting
Consideration and approval of Un Audited Financial Results f…
BSE Filing ↗Board Meeting
To consider and approve the Un Audited Financial Results for…
BSE Filing ↗Board Meeting
consider and approve the Un Audited Financial Results of the…
BSE Filing ↗